TRACON to Report Fourth Quarter and Full Year 2015 Company Highlights and Financial Results on February 18, 2016
SAN DIEGO, Feb. 11, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration …